RESUMO
OBJECTIVE: To compare use of chlorhexidine with use of iodine for preoperative skin antisepsis with respect to effectiveness in preventing surgical site infections (SSIs) and cost. METHODS: We searched the Agency for Healthcare Research and Quality website, the Cochrane Library, Medline, and EMBASE up to January 2010 for eligible studies. Included studies were systematic reviews, meta-analyses, or randomized controlled trials (RCTs) comparing preoperative skin antisepsis with chlorhexidine and with iodine and assessing for the outcomes of SSI or positive skin culture result after application. One reviewer extracted data and assessed individual study quality, quality of evidence for each outcome, and publication bias. Meta-analyses were performed using a fixed-effects model. Using results from the meta-analysis and cost data from the Hospital of the University of Pennsylvania, we developed a decision analytic cost-benefit model to compare the economic value, from the hospital perspective, of antisepsis with iodine versus antisepsis with 2 preparations of chlorhexidine (ie, 4% chlorhexidine bottle and single-use applicators of a 2% chlorhexidine gluconate [CHG] and 70% isopropyl alcohol [IPA] solution), and also performed sensitivity analyses. RESULTS: Nine RCTs with a total of 3,614 patients were included in the meta-analysis. Meta-analysis revealed that chlorhexidine antisepsis was associated with significantly fewer SSIs (adjusted risk ratio, 0.64 [95% confidence interval, [0.51-0.80]) and positive skin culture results (adjusted risk ratio, 0.44 [95% confidence interval, 0.35-0.56]) than was iodine antisepsis. In the cost-benefit model baseline scenario, switching from iodine to chlorhexidine resulted in a net cost savings of $16-$26 per surgical case and $349,904-$568,594 per year for the Hospital of the University of Pennsylvania. Sensitivity analyses showed that net cost savings persisted under most circumstances. CONCLUSIONS: Preoperative skin antisepsis with chlorhexidine is more effective than preoperative skin antisepsis with iodine for preventing SSI and results in cost savings.
Assuntos
Anti-Infecciosos Locais/economia , Anti-Infecciosos Locais/normas , Clorexidina/economia , Clorexidina/normas , Iodo/economia , Iodo/normas , Infecção da Ferida Cirúrgica/prevenção & controle , 2-Propanol/administração & dosagem , 2-Propanol/economia , 2-Propanol/normas , Clorexidina/administração & dosagem , Clorexidina/análogos & derivados , Análise Custo-Benefício , Humanos , Iodo/administração & dosagem , Razão de Chances , Pennsylvania , Soluções Farmacêuticas , Cuidados Pré-Operatórios/economia , Cuidados Pré-Operatórios/métodos , Ensaios Clínicos Controlados Aleatórios como AssuntoRESUMO
A high standard of hand hygiene is achieved by developing, producing and distributing hand disinfectants compliant with the German law for medicinal products. This ensures optimal protection of patients and staff from infections. In addition all local requirements are automatically fulfilled independent of the place within which the product is being used. It is shown that continuous improvement can be stimulated by intensive cooperation between the customer and supplier to ensure that customer expectations are met.
Assuntos
Anti-Infecciosos Locais/normas , Aprovação de Drogas , Indústria Farmacêutica/normas , Desinfecção das Mãos/normas , Indústria Farmacêutica/legislação & jurisprudência , Etanol/normas , Alemanha , Humanos , Controle de QualidadeAssuntos
Infecção Hospitalar/prevenção & controle , Países em Desenvolvimento , Desinfecção das Mãos/normas , Controle de Infecções/métodos , Anti-Infecciosos Locais/química , Anti-Infecciosos Locais/normas , Anti-Infecciosos Locais/uso terapêutico , Educação Continuada , Humanos , Controle de Infecções/economia , Controle de Infecções/normas , Organização Mundial da SaúdeRESUMO
BACKGROUND: In October 2004, The World Health Organization (WHO) launched the World Alliance for Patient Safety. Within the alliance, the first priority of the Global Patient Safety Challenge is to reduce health care-associated infection. A key action within the challenge is to promote hand hygiene in health care globally as well as at the country level through the campaign "Clean Care is Safer Care." As a result, the WHO is developing Guidelines on Hand Hygiene in Health Care, designed to be applicable throughout the world. METHODS: This paper summarizes one component of the global WHO guidelines related to the impact of hand hygiene on the skin of health care personnel, including a discussion of types of skin reactions associated with hand hygiene, methods to reduce adverse reactions, and factors to consider when selecting hand hygiene products. RESULTS: Health care professionals have a higher prevalence of skin irritation than seen in the general population because of the necessity for frequent hand hygiene during patient care. CONCLUSION: Ways to minimize adverse effects of hand hygiene include selecting less irritating products, using skin moisturizers, and modifying certain hand hygiene practices such as unnecessary washing. Institutions need to consider several factors when selecting hand hygiene products: dermal tolerance and aesthetic preferences of users as well as practical considerations such as convenience, storage, and costs.
Assuntos
Anti-Infecciosos Locais/efeitos adversos , Dermatite de Contato/prevenção & controle , Dermatoses da Mão/prevenção & controle , Desinfecção das Mãos , Pessoal de Saúde , Sabões/efeitos adversos , Anti-Infecciosos Locais/normas , Anti-Infecciosos Locais/provisão & distribuição , Comportamento de Escolha , Infecção Hospitalar/prevenção & controle , Dermatite de Contato/etiologia , Emolientes , Fidelidade a Diretrizes , Dermatoses da Mão/induzido quimicamente , Desinfecção das Mãos/métodos , Desinfecção das Mãos/normas , Pessoal de Saúde/educação , Necessidades e Demandas de Serviços de Saúde , Humanos , Controle de Infecções/métodos , Controle de Infecções/normas , Saúde Ocupacional , Projetos Piloto , Guias de Prática Clínica como Assunto , Higiene da Pele/métodos , Sabões/normas , Sabões/provisão & distribuição , Organização Mundial da SaúdeRESUMO
The authors analyze Italian laws, in light of changes introduced with Legislative Act n. 178/91, which regulate products with antiseptic and disinfectant action. A new reclassification of medicinal, cosmetic and health products is considered and proposed. Particular attention is given to marketing criteria adopted by various producers with regard to the form of product presentation.